Here, BMFs were demonstrated to suppress anti-tumor immune response to induce tumor resistance to aPD-L1 immunotherapy at least partly by the overexpressed PD-L1 expression on the surface of BMFs. The gene discussed is CD274; the disease is neoplasm.